Reinilde Heyrman
Direttore Tecnico/Scientifico/R&S presso MEDPACE HOLDINGS, INC.
Posizioni attive di Reinilde Heyrman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MEDPACE HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 | - |
Storia della carriera di Reinilde Heyrman
Precedenti posizioni note di Reinilde Heyrman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | 01/01/2012 | - |
| BELLEROPHON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2014 | - |
| Segretario Aziendale | 01/02/2014 | - |
Formazione di Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Belgio | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Aziende private | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Reinilde Heyrman
- Esperienza
